Recombinant Anti-KDS antibody [EPR4947(2)] (ab150388)
Key features and details
- Produced recombinantly (animal-free) for high batch-to-batch consistency and long term security of supply
- Rabbit monoclonal [EPR4947(2)] to KDS
- Suitable for: WB
- Reacts with: Mouse, Rat, Human
Overview
-
Product name
Anti-KDS antibody [EPR4947(2)]
See all KDS primary antibodies -
Description
Rabbit monoclonal [EPR4947(2)] to KDS -
Host species
Rabbit -
Tested applications
Suitable for: WBmore details
Unsuitable for: Flow Cyt,ICC or IP -
Species reactivity
Reacts with: Mouse, Rat, Human -
Immunogen
Synthetic peptide within Human KDS aa 850 to the C-terminus (C terminal). The exact sequence is proprietary.
Database link: Q9H2K8 -
Positive control
- Jurkat, 293T, K562 and HeLa cell lysates
-
General notes
This antibody was developed as part of a collaboration between Epitomics and the lab of Melanie Cobb at UT Southwestern Medical Center.
This product was previously labelled as TAOK3
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free production
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
Properties
-
Form
Liquid -
Storage instructions
Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles. -
Storage buffer
Preservative: 0.01% Sodium azide
Constituents: 9% PBS, 40% Glycerol, 0.05% BSA, 50% Tissue culture supernatant -
Concentration information loading... -
Purity
Tissue culture supernatant -
Clonality
Monoclonal -
Clone number
EPR4947(2) -
Isotype
IgG -
Research areas
Associated products
-
Alternative Versions
-
Isotype control
-
Positive Controls
-
Recombinant Protein
Applications
Our Abpromise guarantee covers the use of ab150388 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
| Application | Abreviews | Notes |
|---|---|---|
| WB | 1/1000 - 1/10000. Predicted molecular weight: 105 kDa. |
Target
-
Function
Inhibits the basal activity of Jun kinase. Negatively regulated by epidermal growth factor (EGF). When overexpressed, may activate ERK1/ERK2 and JNK/SAPK. -
Tissue specificity
Ubiquitously expressed at a low level, and highly expressed in peripheral blood leukocytes (PBLs), thymus, spleen, kidney, skeletal muscle, heart and liver. -
Sequence similarities
Belongs to the protein kinase superfamily. STE Ser/Thr protein kinase family. STE20 subfamily.
Contains 1 protein kinase domain. -
Post-translational
modificationsAutophosphorylated. Phosphorylated upon DNA damage, probably by ATM or ATR. -
Cellular localization
Cytoplasm. Cell membrane. Also localized to the peripheral cell membrane. - Information by UniProt
-
Database links
- Entrez Gene: 51347 Human
- Entrez Gene: 330177 Mouse
- Entrez Gene: 304530 Rat
- SwissProt: Q9H2K8 Human
- SwissProt: Q9HC79 Human
- SwissProt: Q8BYC6 Mouse
- SwissProt: Q53UA7 Rat
- Unigene: 644420 Human
see all -
Alternative names
- CTCL tumor antigen HD CL 09 antibody
- CTCL-associated antigen HD-CL-09 antibody
- Cutaneous T cell lymphoma tumor antigen HD CL 09 antibody
see all
Images
-
![Western blot - Anti-KDS antibody [EPR4947(2)] (ab150388)](https://www.abcam.com/ps/products/150/ab150388/Images/ab150388-156990-anti-taok3-antibody-epr49472-western-blot.jpg)
Western blot - Anti-KDS antibody [EPR4947(2)] (ab150388)All lanes : Anti-KDS antibody [EPR4947(2)] (ab150388) at 1/1000 dilution
Lane 1 : Jurkat cell lysate
Lane 2 : 293T cell lysate
Lane 3 : K562 cell lysate
Lane 4 : HeLa cell lysate
Lysates/proteins at 10 µg per lane.
Secondary
All lanes : HRP labelled goat anti-rabbit antibody at 1/2000 dilution
Predicted band size: 105 kDa
Protocols
References
ab150388 has been referenced in 1 publication.
- Ormonde JVS et al. TAOK3 Regulates Canonical TCR Signaling by Preventing Early SHP-1-Mediated Inactivation of LCK. J Immunol 201:3431-3442 (2018). PubMed: 30373850
